Hwang, Jun-Eul <br/><br/>
Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.  [electronic resource] 

 -  Yonsei medical journal  Mar 2013 
 - 374-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1976-2437 
<br/><br/><label>Standard No.: </label>10.3349/ymj.2013.54.2.374  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Bevacizumab<br/>Cell Hypoxia<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Knockdown Techniques<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Paclitaxel--pharmacology<br/>Placenta Growth Factor<br/>Pregnancy Proteins--pharmacology<br/>Stomach Neoplasms--drug therapy<br/>Tubulin--genetics<br/>Vascular Endothelial Growth Factor Receptor-1--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors